Literature DB >> 24957833

Comparative efficacies of cloxacillin-daptomycin and the standard cloxacillin-rifampin therapies against an experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.

Cristina El Haj1, Oscar Murillo2, Alba Ribera2, Mireia Vivas2, Dolors Garcia-Somoza3, Fe Tubau3, Javier Cabo4, Javier Ariza2.   

Abstract

We compared the efficacies of daptomycin (doses equivalent to 8 to 10 mg/kg of body weight/day in humans) and cloxacillin alone with those of cloxacillin-rifampin and cloxacillin-daptomycin combinations, using a tissue cage methicillin-susceptible Staphylococcus aureus (MSSA) infection model. Monotherapies were less effective than combinations (P<0.05), and daptomycin resistance emerged. Cloxacillin-daptomycin proved as effective as cloxacillin-rifampin and prevented the appearance of resistance; this combination may be an alternative anti-MSSA therapy, which may offer greater benefits in the early treatment of prosthetic joint infections (PJI).
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24957833      PMCID： PMC4135877          DOI： 10.1128/AAC.02681-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.

Authors:  Abhay Dhand; Arnold S Bayer; Joseph Pogliano; Soo-Jin Yang; Michael Bolaris; Victor Nizet; Guiquing Wang; George Sakoulas
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

2.  Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.

Authors:  O Murillo; A Doménech; A Garcia; F Tubau; C Cabellos; F Gudiol; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

3.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

4.  Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus.

Authors:  W Zimmerli; R Frei; A F Widmer; Z Rajacic
Journal:  J Antimicrob Chemother       Date:  1994-05       Impact factor: 5.790

6.  Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.

Authors:  C Chuard; J C Lucet; P Rohner; M Herrmann; R Auckenthaler; F A Waldvogel; D P Lew
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

7.  Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.

Authors:  P Van der Auwera; J Klastersky; J P Thys; F Meunier-Carpentier; J C Legrand
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

8.  Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.

Authors:  George Sakoulas; Warren Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

9.  Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection.

Authors:  Oscar Murillo; Alejandro Domenech; Gorane Euba; Ricard Verdaguer; Fe Tubau; Javier Cabo; Carmen Cabellos; Francesc Gudiol; Javier Ariza
Journal:  J Infect       Date:  2008-08-19       Impact factor: 6.072

10.  Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.

Authors:  Nagendra N Mishra; Soo-Jin Yang; Liang Chen; Claudette Muller; Azzam Saleh-Mghir; Sebastian Kuhn; Andreas Peschel; Michael R Yeaman; Cynthia C Nast; Barry N Kreiswirth; Anne-Claude Crémieux; Arnold S Bayer
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240
View more
  2 in total

1.  The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?

Authors:  Cristina El Haj; Oscar Murillo; Alba Ribera; Dolors Garcia-Somoza; Fe Tubau; Carmen Cabellos; Javier Cabo; Javier Ariza
Journal:  Med Microbiol Immunol       Date:  2016-09-17       Impact factor: 3.402

2.  Successful long-term antibiotic suppressive therapy in a case of prosthetic valve endocarditis and a case of extensive aortic and subclavian graft infection.

Authors:  Arno M Lechner; Ingrid Pretsch; Uta Hoppe; Rainald Seitelberger; Christian Dinges
Journal:  Infection       Date:  2019-05-23       Impact factor: 3.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.